COGT: Ferrante Karen Jean discloses securities transactions

By AlphaYouPublished Oct 5, 2026Form 4

Stocks in this disclosure

Reported activity

Ferrante Karen Jean

Reporting filer

Ferrante Karen Jean reported Grant or award in Cogent Biosciences, Inc.: 759 units of Stock Option (Right to Buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 5, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (Right to Buy) (derivative)	Ferrante Karen Jean	2026-10-01	A	Grant or award	759	0	759	4 days	Filed terms security Title: Stock Option (Right to Buy) conversion Or Exercise Price: 31.59 transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: A equity Swap Involved: false transaction Shares: 759 transaction Price Per Share: 0 id: F1 transaction Acquired Disposed Code: A exercise Date: 2026-10-01 expiration Date: 2036-10-01 underlying Security Title: Common Stock underlying Security Shares: 759 shares Owned Following Transaction: 759 direct Or Indirect Ownership: D

Stock Option (Right to Buy) (derivative)

Owner: Ferrante Karen Jean
Date: 2026-10-01
Code: A
Action: Grant or award
Quantity: 759
Price: 0
Following holdings: 759
Reporting delay: 4 days
Filed terms and references: Filed terms
security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 31.59
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 759
transaction Price Per Share: 0
id: F1
transaction Acquired Disposed Code: A
exercise Date: 2026-10-01
expiration Date: 2036-10-01
underlying Security Title: Common Stock
underlying Security Shares: 759
shares Owned Following Transaction: 759
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Ferrante Karen Jean: Director.
F1: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Option (Right to Buy) (derivative)

Ferrante Karen Jean

2026-10-01

Grant or award

759

4 days

Filed terms

security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 31.59
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 759
transaction Price Per Share: 0
id: F1
transaction Acquired Disposed Code: A
exercise Date: 2026-10-01
expiration Date: 2036-10-01
underlying Security Title: Common Stock
underlying Security Shares: 759
shares Owned Following Transaction: 759
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Ferrante Karen Jean: Director.

F1: The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.